AVRX (AVRX) Stock Price, News & Analysis

Name: AVRX (AVRX) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

AVRX

Published by Stock Titan Data refreshed August 10, 2026

What Changed

Latest news August 10, 2026
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

Company Description

This page collects what Stock Titan holds for AVRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

Last updated:

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

August 10, 2026

—

Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

private placement

AVRX has 1 recent news article. Key topics include private placement. View all AVRX news →

SEC Filings

View All

No SEC filings available for AVRX.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months